Technology
Novel mRNA delivery vehicle provides alternative to LNPs for SARS-CoV-2 vaccines – News-Medical.Net
Researchers in the United States have developed an alternative messenger RNA (mRNA) delivery platform to the lipid nanoparticles that are currently used in vaccines…
Researchers in the United States have developed an alternative messenger RNA (mRNA) delivery platform to the lipid nanoparticles that are currently used in vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19).
The lipid nanoparticle (LNP) delivery vehicles have inherent immunostimulatory properties that can induce adverse events such as allergic reactions.
Now, Ronald Levy and colleagues from Stanford University…
-
Noosa News22 hours agoItalian Film Festival, Brisbane: All the Details
-
Noosa News18 hours agoKatter and pregnant wife crash-land plane in outback Qld
-
Noosa News18 hours agoFollowing Up Hottest 100 of Australian Songs Success with a Second Documentary About Your Life and Career: Jimmy Barnes Talks ‘Working Class Man’
-
Business24 hours ago7% lift in profits and guidance upgrade